在临床上呈现为渐进的超核麻与渐进的步态结
Renpei Sengoku1,2, Akira Arakawa1,2, Tomoyasu Matsubara1,2
1Department of Neuropathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology (Brain Bank for Aging Research), Tokyo, Japan.
Movement disorders clinical practice
|April 22, 2025
概括
阿吉罗菲尔粒细胞疾病 (AGD) 是一种病,可伴有帕金森症和认知衰退. 这项研究证实AGD病理延伸到中脑,支持其在这些神经疾病中的作用.
科学领域:
- 神经病理学神经病理学
- 神经退行性疾病 神经退行性疾病
- 陶氏病变是一种病变.
背景情况:
- 阿尔吉罗菲尔粒细胞疾病 (AGD) 是一种由阿尔吉罗菲尔粒细胞积累所定义的病,主要导致晚发性失忆性痴呆症.
- AGD,黑色物质参与和帕金森症之间的潜在联系需要进一步的生物化学研究.
研究的目的:
- 调查中脑中AGD病理的程度,包括黑质.
- 在AGD病例中,将组织病理学和生化发现与帕金森症和认知障碍相关联.
主要方法:
- 一个80岁的男性患有渐进式帕金森症和认知衰退的案例研究.
- 神经病理学检查包括宏观,显微镜,西式涂抹和免疫电子显微镜.
主要成果:
- 患者表现出帕金森症 (步态结,姿势不稳定,勃拉迪基尼西亚) 和认知障碍.
- 组织病理学揭示了在边缘系统,黑色物质和中脑体中的argyrophilic粒.
- 生物化学分析证实了AGD特异性的tau病理在核和中脑.
结论:
- AGD可以呈现帕金森症,由中脑病理和生化证据支持.
- 在对患有帕金森症和认知障碍的老年人进行差异诊断时,应考虑AGD.
相关概念视频
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Cross-bridge Cycle
115.8K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
115.8K
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


